AstraZeneca rises on delisting report

Shares in AstraZeneca Pharma India Ltd rose following a report citing two people familiar with the matter,that its parent AstraZeneca Plc was planning to delist the Indian unit and was in talks with top investment banks. We continue to consider two options,reducing our shareholding to the new statutory maximum of 75 and delisting,the report quoted the Anglo-Swedish drugmaker,which owns 90 of the Indian unit,as saying. As a company policy,we do not comment on market speculations,AstraZeneca India8217;s spokesman told Reuters on Monday. At 1:09 p.m.,shares of AstraZeneca Pharma India were up 11 percent at 2,319 rupees.

Stocks More on AstraZeneca Pharma India Ltd

Company INFO More on AstraZeneca Pharma India Ltd